2,000-acre Rowen bioscience campus announces first buildings. Take a look.

October 13, 2025 | By: Zachary Hansen

Originally published in The AJC.

After decades of planning and preparation, one of Georgia’s largest economic development projects is about to start construction in earnest.

Rowen, a planned 2,000-acre life sciences campus in Gwinnett County near Dacula, announced Monday it will soon start building its first facility called the Rowen Convergence Center. It’s a 10,000-square-foot development intended to anchor a forthcoming mixed-use village featuring apartments, restaurants, a hotel, parks and retail.

Modeled after North Carolina’s Research Triangle, Rowen aims to provide a development that connects employers with students from Georgia’s largest universities. Rowen Foundation President Mason Ailstock said a bustling village is required to create the vibrancy needed for companies to add their facilities to the campus.

“We had a vision, we created a place with the real estate, and now we’re bringing it to life,” he told The Atlanta Journal-Constitution.

The convergence center was announced Monday at Rowen Convergence Summit at the Woodruff Arts Center in Midtown Atlanta. Rowen officials expect to start construction next year and open the center by mid-2027.

First envisioned more than 20 years ago, the Rowen project’s work so far has focused on behind-the-scenes land acquisition, zoning and infrastructure. The enormous site is equidistant from Atlanta, Athens and Gainesville along Ga. 316, aiming to attract the talents of each city’s universities.

The campus has spent the last two years undergoing $32 million of infrastructure preparation, including road and utility integration. It connects the forthcoming village area to several corporate development sites that are currently being marketed to prospective companies across the life sciences and technology industries.

Newsletters

Rowen Stakeholder Newsletter: March 25, 2026

Rowen’s First Tenant is a Win for Georgia’s Future UCB, a global biopharmaceutical company focused on treatments for severe neurological and autoimmune conditions, has selected Rowen as the site of its new U.S. biologics manufacturing campus — bringing $2 billion in direct investment, more than 330 permanent jobs and approximately $5 billion in total economic impact. For everyone who has […]

Newsletters

Rowen Site Selection Newsletter: March 25, 2026

UCB Selects Rowen for $2B Biopharma Manufacturing Campus First tenant milestone validates Rowen’s innovation community model and signals the establishment of a new life sciences hub in Georgia Global biopharmaceutical company UCB has selected Rowen as the site of its new U.S. biologics manufacturing campus: a $2 billion direct investment expected to create more than 330 permanent jobs and generate approximately $5 […]

Announcements

UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus

First tenant milestone validates Rowen’s innovation community model and signals the start of a new life sciences hub in Gwinnett County.